Bellco, among the market leaders in systems for dialysis and extracorporeal blood purification, has consolidated its market position through the acquisition of HBiofluids. HBiofluids was formed as a pharmaceutical company in 2002 by Argentinean businessman Juan Boris Scalesciani and produces fluids for dialysis, haemofiltration and intravenous therapy. HBiofluids is certified for its application of GMP (Good Manufacturing Practice), the strictest standard governing the production of pharmaceutical products. HBiofluids currently supplies some of the leading enterprises in the field of extracorporeal blood purification for chronic and intensive care patients, and for home dialysis and peritoneal dialysis too.

Visit the website